Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 9
2006 5
2007 2
2008 3
2009 4
2010 1
2011 2
2012 2
2013 1
2014 1
2015 1
2017 3
2018 2
2019 2
2020 6
2021 2
2022 6
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
Systemic treatment of gastric cancer.
Morabito A, Carillio G, Longo R. Morabito A, et al. Among authors: longo r. Crit Rev Oncol Hematol. 2009 Jun;70(3):216-34. doi: 10.1016/j.critrevonc.2008.08.005. Epub 2008 Oct 1. Crit Rev Oncol Hematol. 2009. PMID: 18829344 Review.
The paradigm of personalized therapy in oncology.
Gasparini G, Longo R. Gasparini G, et al. Among authors: longo r. Expert Opin Ther Targets. 2012 Mar;16 Suppl 1:S7-16. doi: 10.1517/14728222.2011.637921. Epub 2011 Nov 11. Expert Opin Ther Targets. 2012. PMID: 22073968 Review.
Anti-angiogenic and anti-HER therapy.
Gasparini G, Sarmiento R, Longo R. Gasparini G, et al. Among authors: longo r. Biomed Pharmacother. 2006 Jul;60(6):263-5. doi: 10.1016/j.biopha.2006.06.001. Epub 2006 Jun 23. Biomed Pharmacother. 2006. PMID: 16815667 Review.
Prognostic and predictive indicators in operable breast cancer.
Morabito A, Magnani E, Gion M, Sarmiento R, Capaccetti B, Longo R, Gattuso D, Gasparini G. Morabito A, et al. Among authors: longo r. Clin Breast Cancer. 2003 Feb;3(6):381-90. doi: 10.3816/CBC.2003.n.002. Clin Breast Cancer. 2003. PMID: 12636883 Review.
62 results